Skip to content

Persistent Pain After Reconstruction Following Mastectomy

Persistent Pain After Reconstruction Following Mastectomy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01738048
Enrollment
1352
Registered
2012-11-30
Start date
2008-01-31
Completion date
2008-04-30
Last updated
2012-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Chronic Pain

Keywords

Pain, Neuropathic pain, Chronic pain

Brief summary

A cross sectional study to determine the prevalence of persistent pain after reconstructive surgery after mastectomy for breast cancer, with a comparative analysis of a cohort treated with mastectomy without reconstruction.

Detailed description

The aim of the study is to determine if reconstruction of the breast after mastectomy increases the risk of reporting persistent pain 2-3 years after surgery.

Interventions

Reconstructive surgery after mastectomy, either by expander or autologous tissue. Includes both primary and secondary reconstruction

Sponsors

Danish Breast Cancer Cooperative Group
CollaboratorOTHER
Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients with unilateral primary breast cancer aged 18-70 years

Exclusion criteria

* recurrent cancer * other malignancy * emigration * non-standardized treatment

Design outcomes

Primary

MeasureTime frameDescription
The risk of developing persistent if reconstructedCross-sectional, 2-3 years after surgery for breast cancerThe risk of developing persistent if reconstructed compared to patients mastectomized without reconstruction expressed as an odds ratio.

Secondary

MeasureTime frameDescription
Prevalence of persistent pain after reconstruction after mastectomyCross-sectional, 2-3 years after surgery for breast cancerSelf reported pain expressed as a percentage of the population of patients reconstructed with expander and autologous tissue. Pain intensity measured with a numerical rating scale 0-10, divided in mild (NRS 1-3), moderate (4-6) and severe pain (7-10). Patients regarded as having clinically relevant pain: NRS 4 or above, at least at a weekly basis.
Prevalence of sensory disturbances after reconstruction after mastectomyCross-sectional, 2-3 years after surgery for breast cancer

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026